» Articles » PMID: 25396304

An Age-period-cohort Analysis of Cancer Incidence Among the Oldest Old, Utah 1973-2002

Overview
Publisher Routledge
Specialty Public Health
Date 2014 Nov 15
PMID 25396304
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We used age-period-cohort (APC) analyses to describe the simultaneous effects of age, period, and cohort on cancer incidence rates in an attempt to understand the population dynamics underlying their patterns among those aged 85+. Data from the Utah Cancer Registry (UCR), the US Census, the National Center for Health Statistics (NCHS), and the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) programme were used to generate age-specific estimates of cancer incidence at ages 65-99 from 1973 to 2002 for Utah. Our results showed increasing cancer incidence rates up to the 85-89 age group followed by declines at ages 90-99 when not confounded by the separate influences of period and cohort effects. We found significant period and cohort effects, suggesting the role of environmental mechanisms in cancer incidence trends between the ages of 85 and 100.

Citing Articles

When Do Tumours Develop? Neoplastic Processes Across Different Timescales: Age, Season and Round the Circadian Clock.

Bieuville M, Dujon A, Raven N, Ujvari B, Pujol P, Eslami-S Z Evol Appl. 2024; 17(10):e70024.

PMID: 39444444 PMC: 11496201. DOI: 10.1111/eva.70024.


Trend of incidence rate of age-related diseases: results from the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database in Korea: a cross- sectional study.

Ryou I, Lee S, Mun H, Lee J, Chun S, Cho K BMC Geriatr. 2023; 23(1):840.

PMID: 38087197 PMC: 10714524. DOI: 10.1186/s12877-023-04578-7.


Modeling of senescent cell dynamics predicts a late-life decrease in cancer incidence.

Bieuville M, Tissot T, Robert A, Henry P, Pavard S Evol Appl. 2023; 16(3):609-624.

PMID: 36969142 PMC: 10033854. DOI: 10.1111/eva.13514.


Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.

Zhu S, Wang J, Zellmer L, Xu N, Liu M, Hu Y J Cancer. 2022; 13(9):2810-2843.

PMID: 35912015 PMC: 9330459. DOI: 10.7150/jca.72628.


Profound synchrony of age-specific incidence rates and tumor suppression for different cancer types as revealed by the multistage-senescence model of carcinogenesis.

Richardson R, Anghel C, Deng D Aging (Albany NY). 2021; 13(20):23545-23578.

PMID: 34695806 PMC: 8580351. DOI: 10.18632/aging.203651.


References
1.
Ukraintseva S, Yashin A . How individual age-associated changes may influence human morbidity and mortality patterns. Mech Ageing Dev. 2001; 122(13):1447-60. DOI: 10.1016/s0047-6374(01)00277-9. View

2.
Hawkes K, Smith K, Blevins J . Human actuarial aging increases faster when background death rates are lower: a consequence of differential heterogeneity?. Evolution. 2012; 66(1):103-14. PMC: 4010320. DOI: 10.1111/j.1558-5646.2011.01414.x. View

3.
Carstensen B . Age-period-cohort models for the Lexis diagram. Stat Med. 2006; 26(15):3018-45. DOI: 10.1002/sim.2764. View

4.
Yang Y . Trends in U.S. adult chronic disease mortality, 1960-1999: age, period, and cohort variations. Demography. 2008; 45(2):387-416. PMC: 2831365. DOI: 10.1353/dem.0.0000. View

5.
Vaupel J, Carey J, Christensen K, Johnson T, Yashin A, Holm N . Biodemographic trajectories of longevity. Science. 1998; 280(5365):855-60. DOI: 10.1126/science.280.5365.855. View